Local drug makers boosting R&D spending

Published: 2012-08-28 06:59:00

Updated: 2012-08-28 06:59:00

Korea’s pharmaceutical companies have been spending more on research and development (R&D) projects to strengthen their technology leadership, industry data showed Monday.

Pharmaceutical information provider Yakup.com said Monday that R&D spending of 52 listed companies averaged 7.4 percent of...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK